Dr. Reddy's Laboratories is targeting a double-digit growth rate in India for the fiscal year 2025. The pharmaceutical company plans to leverage its diverse portfolio, including branded and generic medications, to achieve this ambitious goal. This growth strategy is part of the company's broader efforts to enhance its market presence and operational efficiency in one of its key markets.